4. Non-Hodgkin-Lymphome Flashcards

1
Q

(NHL)

Sonderformen (3)

A
  • follikuläres Lymphom
  • Burkitt-Lymphom
  • Haarzellleukämie
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

(NHL)

follikuläres Lymphom: Ätiologie

A

Translokation t(14,18)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

(NHL)

follikuläres Lymphom: Histologie

A

Keimzentrumslymphom

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

(NHL)

Haarzellleukämie: Blutausstrich

A

Haarzellen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

(NHL)

Haarzellleukämie: Therapie

A

Chemotherapie mit Purinanaloga

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

(NHL)

Burkitt-Lymphom: Charakteristik

A

sehr aggressiv

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

(NHL)

Burkitt-Lymphom: Assoziation

A

EBV-Infektion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

(NHL)

Leitsymptome (2)

A
  • B-Symptomatik
  • schmerzlose Lymphadenopathie
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

(NHL)

Befund

A

Splenomegalie

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

(NHL)

Laborbefund

A

Panzytopenie

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

(NHL)

Diagnosesicherung (2)

A
  • Lymphknotenexstirpation
  • Immunhistochemie
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

(NHL)

Immunhistochemie: B-Zell-Lymphome

A

CD20-positiv

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

(NHL)

Immunhistochemie: T-Zell-Lymphome

A

CD3-positiv

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

(NHL)

Klassifikation (2)

A
  • niedrigmalignes (indolentes)
  • hochmalignes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

(NHL)

Stadien I-II: Charakteristik

A

lokalisierter Befund

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

(NHL)

Stadien III-IV: Charakteristik

A

systemische Ausbreitung

17
Q

(NHL)

niedrigmalignes-: Therapieintention der Stadien I-II

18
Q

(NHL)

niedrigmalignes-: Therapie der Stadien I-II

19
Q

(NHL)

niedrigmalignes-: Therapieintention der Stadien III-IV

A

palliative

20
Q

(NHL)

niedrigmalignes-: Therapiemöglichkeiten der Stadien III-IV (2)

A
  • “Watch and Wait”
  • Polychemotherapie
21
Q

(NHL)

Polychemotherapie: Schema

22
Q

(NHL)

Polychemotherapie: Schema bei B-Zell-NHL

23
Q

(NHL)

hochmalignes NHL: Therapieintention

24
Q

(NHL)

hochmalignes NHL: Therapie

A

Polychemotherapie

25
(NHL) lokalisierter Befund: Stadien (2)
I-II
26
(NHL) systemische Ausbreitung: Stadien (2)
III-IV
27
(NHL) kurative Therapie: Indikationen (2)
- niedrigmalignes- in Stadien I-II - hochmalignes-
28
(NHL) palliative Therapie: Indikation
- niedrigmalignes- in Stadien III-IV
29
(NHL) Radiation: Indikation
niedrigmalignes- in Stadien I-II
30
(NHL) Polychemotherapie: Indikationen (2)
- niedrigmalignes- in Stadien III-IV - hochmalignes-
31
(NHL) CHOP: Indikation
NHL
32
(NHL) R-CHO: Indikation
B-Zell-NHL